Literature DB >> 5680902

Carbohydrate metabolism studies in cirrhosis of the liver.

M Carneiro de Moura, A Ginestal Cruz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5680902     DOI: 10.1007/bf02237575

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  27 in total

1.  Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, non-esterified fatty acid, and insulin during oral glucose-tolerance tests.

Authors:  C N HALES; P J RANDLE
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test.

Authors:  P A MARKS; J S BISHOP
Journal:  J Clin Invest       Date:  1957-02       Impact factor: 14.808

3.  Hepatic hypoglycemia; its occurrence in congestive heart failure.

Authors:  S M MELLINKOFF; P A TUMULTY
Journal:  N Engl J Med       Date:  1952-11-13       Impact factor: 91.245

4.  ALCOHOL HYPOGLYCEMIA. I. CARBOHYDRATE METABOLISM OF PATIENTS WITH CLINICAL ALCOHOL HYPOGLYCEMIA AND THE EXPERIMENTAL REPRODUCTION OF THE SYNDROME WITH PURE ETHANOL.

Authors:  N Freinkel; D L Singer; R A Arky; S J Bleicher; J B Anderson; C K Silbert
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

5.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

6.  Glucose tolerance in hypertensive patients on long-term diuretic therapy.

Authors:  A Breckenridge; T A Welborn; C T Dollery; R Fraser
Journal:  Lancet       Date:  1967-01-14       Impact factor: 79.321

7.  Azotemia and glucose intolerance.

Authors:  J M Cerletty; N H Engbring
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

8.  Cirrhosis of the liver and Diabetes mellius. A study of 140 combined cases.

Authors:  D Müting; N Lackas; H Reikowski; S Richmond
Journal:  Ger Med Mon       Date:  1966-10

9.  Comparison of response to intravenously administered sodium tolbutamide in milk diabetic and non-diabetic subjects.

Authors:  R H UNGER; L L MADISON
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

10.  [Intravenous injections of glucose, insulin and tolbutamide in healthy persons, diabetics, cirrhotics, and patients with insuloma (together with a contribution on the diagnostic value of the tolbutamide tests)].

Authors:  W CREUTZFELDT; K WILLE; H KAUP
Journal:  Dtsch Med Wochenschr       Date:  1962-10-26       Impact factor: 0.628

View more
  7 in total

1.  Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.

Authors:  A V Greco; G Ghirlanda; C Patrono; G Fedili; R Manna
Journal:  Acta Diabetol Lat       Date:  1974 Jul-Aug

2.  Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.

Authors:  D Berkowitz
Journal:  Am J Dig Dis       Date:  1969-10

3.  Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.

Authors:  L Altomonte; A V Greco; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Acta Diabetol Lat       Date:  1979 Apr-Jun

4.  Clinical investigation on abnormal glucose tolerance in liver cirrhosis.

Authors:  K Kato; S Kikuchi; M Ito
Journal:  Gastroenterol Jpn       Date:  1976

5.  Glycerol clearance in alcoholic liver disease.

Authors:  D G Johnston; K G Alberti; R Wright; P G Blain
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

6.  Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis.

Authors:  H O Conn; W Schreiber; S G Elkington
Journal:  Am J Dig Dis       Date:  1971-03

7.  Oridonin prevents insulin resistance-mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy.

Authors:  Fangfang Wen; Weishan Zhuge; Jian Wang; Xiaoai Lu; Ruimin You; Leping Liu; Qichuan Zhuge; Saidan Ding
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.